Abstract

Endosomal toll-like receptors such as TLR7 and TLR9 are often upregulated in autoimmune settings. Interestingly, studies in animal models have largely confirmed a dichotomous function of these two receptors, with TLR7 being pathogenic and TLR9 being protective. We here introduce these TLRs and discuss data supporting a role for each in five different autoimmune disorders based on both human and animal data. Furthermore, we present a comprehensive list of currently known agonists and antagonists of TLR7 and TLR9 activation and signaling, speculating on the potential use of these therapeutics in autoimmunity.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call